The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial.
Jingjing ZhouJian YangXuequan ZhuTarek ZghoulLei FengRunsen ChenGang WangPublished in: Therapeutic advances in psychopharmacology (2020)
ClinicalTrials.gov, NCT03131050. Registered on 18 April 2017.